HUMIRA (adalimumab)

by ABBVIE INC

Dosages/Routes/Forms

Dosages/Routes/Forms
StrengthForm/RouteMarketing Status
40MG/0.8MLSYRINGE1
40MG/0.8MLVIAL1

Approval History

Manufacturing Change or Addition
    Labeling Revision
    Labeling Revision
    Labeling Revision
    Labeling Revision
    Labeling Revision
    Manufacturing Change or Addition
    New or Modified Indication New or Modified Indication
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement
    Supplement